symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
HSDT,7.8,1.278489,399294,4414550,0,5.69-20.95,-0.22,"Helius Medical Technologies, Inc.",USD,0001610853,US42328V5049,42328V504,NASDAQ Capital Market,NASDAQ,Medical Devices,https://heliusmedical.com,"Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.",Mr. Dane Carl Andreeff,Healthcare,US,26,215 944 6100,642 Newtown Yardley Road,Newtown,PA,18940,0.262578,1.28258,https://financialmodelingprep.com/image-stock/HSDT.png,2014-06-27,False,False,True,False,False
